- Home
- Life Sciences
- Diagnostics
- In Vitro Diagnostic
- The World Market for Point of Care (POC) Diagnostics
The World Market for Point of Care (POC) Diagnostics
$ 4 200
- December 2012
- by Kalorama Information
- 200
Summary
Table of Contents
View Report
Search Inside
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
- Molecular POC Test Products and the Future of Molecular POC
- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
- Regional Breakout of POC Market (US, EU, Japan, ROW)
- Blood Glucose Monitoring Markets
- Small Footprint and POC Chemistry Systems
- Small Footprint and POC Hematology Systems
- Small Footprint and POC Immunoassay Systems
- Non-Invasive Testing Innovations
- Miniaturization and Microfluidics Innovations
- POC Test Revenues of Selected IVD Companies
- Selected Rapid HIV Tests on the Market
- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
- Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
- Molecular POC Test Products and the Future of Molecular POC
- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
- Regional Breakout of POC Market (US, EU, Japan, ROW)
- Blood Glucose Monitoring Markets
- Small Footprint and POC Chemistry Systems
- Small Footprint and POC Hematology Systems
- Small Footprint and POC Immunoassay Systems
- Non-Invasive Testing Innovations
- Miniaturization and Microfluidics Innovations
- POC Test Revenues of Selected IVD Companies
- Selected Rapid HIV Tests on the Market
- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
- Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
ASK INFO SPECIALIST 24/7
Geoffrey - online now
+1 718 618 4302
Send Message @Geoffrey
Share
Global In Vitro Diagnostic Industry : Latest Reports
2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic ...
2013 Analysis of the Global Coagulation Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new 302-page report from Venture Planning Group provides analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and ...
2013 Analysis of the Global Clinical Chemistry and Immunodiagnostic Markets: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profilels of Leading Suppliers
- $ 7 500
- Industry report
- February 2013
- by Venture Planning Group
This new 464-page report from Venture Planning Group provides analysis of the global clinical chemistry and immunodiagnostic markets, including emerging tests, technologies, instrumentation, sales forecasts ...
More Reports:
In Vitro Diagnostic in China (34)
Global In Vitro Diagnostic Industry : Latest Downloads
In Vitro Diagnostic Market Brief
- Industry report
- April 2013
- 4 pages
... Middleware: created to aid market planners interested in strengthen- ing their firm S position while accelerating the growth of the informatics segment of the clinical laboratory. Sales effort: developed ...
In Vitro Diagnostic Industry Brief
- Industry report
- April 2013
- 5 pages
Tissue Culture Business Brief
- Industry report
- March 2013
- 17 pages
... To remain open for acceptance till the next working day at the same time. Financial bid will be opened only for technically accepted tenders for further evaluation. Tender form for tissue culture ...
In Vitro Diagnostic Market Analysis
3 months agoMicrobiology : Innovation And Technology Tren ...
5 months agoWorld In Vitro Diagnostic Industry Brief
5 months agoIn Vitro Sector Brief
9 months agoTissue Culture Sector Brief
9 months agoIn Vitro Industry Brief
9 months agoIn Vitro Industry Brief
9 months agoMore Reports:
In Vitro Diagnostic in Germany (5)
Related Market Segments :
In Vitro Instrument
Molecular Assay
In Vitro Diagnostics Application
In Vitro Diagnostic Reagent
Point-of-care-testing
Company Reports
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.
